SOSV

Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Shawn Broderick

Venture Partner

Stephen Chambers

General Partner

Navin Danapal

Director, South East Asia

Cyril Ebersweiler

General Partner

Hiruy Ephrem

Analyst

Sheng Ge

Partner

Weichang Ge

Analyst

TR Harrington

Partner

Bradford Higgins JD

Venture Partner

Mohan S. Iyer

General Partner

Benjamin Joffe

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Brian Murphy

Finance Director

Sean O'Sullivan

Managing Partner

Oscar Ramos

General Partner

Eric Ramsay

Analyst

Susan Schofer Ph.D

Partner

Parikshit Sharma

Principal

Duncan Turner

General Partner

Pae Wu

General Partner

Sabriya Stukes Ph.D

Partner

Past deals in Europe

Ostoform

Convertible Note in 2025
Ostoform Limited is a medical device company based in Dublin, Ireland, specializing in products designed to manage skin complications for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform has developed patented technologies aimed at enhancing ostomy skin health. Its flagship products include a mouldable seal that fits securely around the stoma, preventing corrosive output from contacting the skin, and FLOWASSIST, which directs stoma output away from the skin to minimize irritation and swelling. By addressing these significant challenges faced by ostomy patients, Ostoform aims to improve comfort and overall quality of life, positioning itself as a potential leader in the global ostomy care market.

XFuel

Series A in 2025
XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Oxyle

Seed Round in 2025
Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.

Reach Industries

Convertible Note in 2025
Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Samphire Neuroscience

Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Vitarka Therapeutics

Seed Round in 2024
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Machine Medicine Technologies

Convertible Note in 2024
Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

DeepSpin

Convertible Note in 2024
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Flow Neuroscience

Convertible Note in 2024
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Valanx Biotech

Seed Round in 2024
VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

GlowDx

Convertible Note in 2024
Founded in 2015, GlowDx specializes in developing point-of-care diagnostic platforms. Utilizing novel molecular technology and machine learning, the company aims to democratize access to diagnostics globally, enabling timely detection of infectious diseases and reducing disease burden.

XFuel

Seed Round in 2024
XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Sundew

Series B in 2024
Founded in 2018, Sundew is a biotechnology company based in Copenhagen. It specializes in providing biological services for treating aquatic pests and diseases using precision fermentation.

CroBio

Seed Round in 2024
CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Nukoko

Seed Round in 2024
Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Samphire Neuroscience

Pre Seed Round in 2024
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

CargoKite

Convertible Note in 2023
CargoKite is a Munich-based company founded in 2022 that specializes in micro cargo ships aimed at enhancing maritime logistics. The company has developed sailing cargo vessels that leverage high-altitude winds for propulsion, promoting emission-free shipping solutions. By utilizing this innovative technology, CargoKite enables clients to operate small ships with greater efficiency while significantly reducing personnel costs through digitization. The vessels are designed for optimal trackability and autonomous operation, eliminating the need for large energy storage systems and contributing to the decarbonization of the shipping industry.

Valanx Biotech

Seed Round in 2023
VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

CroBio

Convertible Note in 2023
CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Nukoko

Convertible Note in 2023
Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Hexafly

Convertible Note in 2023
Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Reach Industries

Seed Round in 2023
Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Valanx Biotech

Seed Round in 2023
VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Samphire Neuroscience

Convertible Note in 2023
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Pear Bio

Series A in 2023
Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Nukoko

Seed Round in 2023
Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Vitarka Therapeutics

Seed Round in 2023
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Sundew

Convertible Note in 2023
Founded in 2018, Sundew is a biotechnology company based in Copenhagen. It specializes in providing biological services for treating aquatic pests and diseases using precision fermentation.

PILI

Series A in 2023
Founded in Paris, France in 2012, PILI Inc. specializes in the research and manufacture of bio-fabricated colors using microorganisms. The company designs enzymes and fermentation biotechnologies to efficiently transform sugar into renewable and long-lasting dyes and pigments.

Pear Bio

Convertible Note in 2023
Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

CroBio

Seed Round in 2023
CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Moirai Biodesign

Seed Round in 2023
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Japet Medical

Convertible Note in 2023
Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

Multus

Series A in 2023
Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

QV Bioelectronics

Seed Round in 2023
QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Nukoko

Pre Seed Round in 2023
Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Metabolomic Diagnostics

Seed Round in 2022
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Oxyle

Pre Seed Round in 2022
Oxyle specializes in wastewater treatment, focusing on the removal of hazardous micropollutants such as pesticides, chemicals, pharmaceuticals, and endocrine disruptors. Serving industries like pharmaceuticals, biotech, chemicals, food & beverage, electronics, hospitals, and wastewater plants, Oxyle's innovative technology helps reduce toxic pollutants and carbon emissions while providing regulatory relief to clients.

Vitarka Therapeutics

Seed Round in 2022
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Hexafly

Seed Round in 2022
Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Samphire Neuroscience

Seed Round in 2022
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Machine Medicine Technologies

Seed Round in 2022
Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Reach Industries

Seed Round in 2022
Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Chronos DX

Seed Round in 2022
Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

GlowDx

Seed Round in 2022
Founded in 2015, GlowDx specializes in developing point-of-care diagnostic platforms. Utilizing novel molecular technology and machine learning, the company aims to democratize access to diagnostics globally, enabling timely detection of infectious diseases and reducing disease burden.

Moirai Biodesign

Convertible Note in 2022
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

XFuel

Venture Round in 2022
XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

CargoKite

Seed Round in 2022
CargoKite is a Munich-based company founded in 2022 that specializes in micro cargo ships aimed at enhancing maritime logistics. The company has developed sailing cargo vessels that leverage high-altitude winds for propulsion, promoting emission-free shipping solutions. By utilizing this innovative technology, CargoKite enables clients to operate small ships with greater efficiency while significantly reducing personnel costs through digitization. The vessels are designed for optimal trackability and autonomous operation, eliminating the need for large energy storage systems and contributing to the decarbonization of the shipping industry.

SensiPass

Convertible Note in 2022
SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security. Founded in 2013 and headquartered in Dublin, Ireland, the company employs a patented interactive platform that utilizes personal human interaction, registered biometric data, and unique virtual objects to create sophisticated digital signatures. This innovative approach replaces traditional passwords and PINs, significantly mitigating risks associated with identity theft and insider threats, particularly in critical sectors such as energy, transportation, communications, government, and defense. SensiPass’s products, including SensiAR and ImmersiveID, enable rapid authentication in various environments, including augmented and virtual reality. The company has received multiple accolades for its contributions to cybersecurity innovation, underscoring its commitment to providing robust identity assurance for users accessing both digital and physical assets.

Moona

Convertible Note in 2022
Moona is an innovative company that specializes in enhancing sleep quality through temperature regulation. Founded in 2016 and based in Paris, France, Moona has developed a sophisticated sleep device that adapts to the user’s head temperature throughout the night, optimizing comfort for better rest. The system utilizes a unique water-based cooling pillow pad made from a thin membrane and memory foam, which facilitates a smooth transition between cooling and heating. This design helps users achieve the ideal body temperature conducive to sleep, ultimately improving overall sleep experiences.

QV Bioelectronics

Seed Round in 2022
QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

MotionsCloud

Seed Round in 2022
MotionsCloud is a technology company that specializes in automating damage detection and assessment for property and vehicle insurance claims using computer vision and artificial intelligence. By streamlining the claims process, MotionsCloud significantly reduces the claim cycle time from ten days to just three hours and can cut claims processing costs by up to 75%. The company's innovative solutions enhance the overall experience for customers and improve productivity for insurance providers. MotionsCloud serves a diverse range of clients across the United States, Europe, and Southeast Asia, demonstrating its impact on the global insurance industry.

IPOR

Funding Round in 2022
IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

Metabolomic Diagnostics

Convertible Note in 2022
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

SunGreenH2

Seed Round in 2022
Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

AromatEco

Convertible Note in 2022
AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX

Seed Round in 2022
LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Sundew

Seed Round in 2022
Founded in 2018, Sundew is a biotechnology company based in Copenhagen. It specializes in providing biological services for treating aquatic pests and diseases using precision fermentation.

Hexafly

Convertible Note in 2022
Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

ROVENSO

Convertible Note in 2021
ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Valanx Biotech

Convertible Note in 2021
VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Quidli

Seed Round in 2021
Quidli is a Paris-based company founded in 2018 that develops technological infrastructure to facilitate the exchange of equity for labor. Its platform enables businesses to distribute ownership equity as compensation, connecting companies, workers, freelancers, and investors. By leveraging blockchain technology, Quidli allows companies to split equity and incentivize contributions from individuals, thereby enhancing employee engagement and productivity. The platform also offers job security for workers, enabling them to pursue projects aligned with their interests while providing companies with a tool for recruitment. Overall, Quidli aims to create a more connected and equitable labor market.

Samphire Neuroscience

Seed Round in 2021
Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Reach Industries

Seed Round in 2021
Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

LOOX

Pre Seed Round in 2021
LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Criam

Seed Round in 2021
Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.

Synthace

Series C in 2021
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Coffee Exchange

Seed Round in 2021
Coffee Exchange operates a digital marketplace that aims to revolutionize the global coffee trading industry by promoting transparency and efficiency. The platform facilitates direct trade between coffee producers and roasters, eliminating intermediaries and enabling producers to earn significantly higher revenues. By providing real-time information and streamlining the entire green coffee trading process—from farm gate to consumer—Coffee Exchange enhances the supply chain while reducing costs for roasters. The company's services include coffee evaluation, logistics, customs clearance, quality inspections, and marketing support, ensuring a comprehensive solution for all participants in the trade. Currently, Coffee Exchange has over 1,100 coffee roasters in China engaged with select producers from countries such as Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. The platform is being trialed in the United States, with plans for expansion into the UK and South Korea.

Ostoform

Series A in 2021
Ostoform Limited is a medical device company based in Dublin, Ireland, specializing in products designed to manage skin complications for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform has developed patented technologies aimed at enhancing ostomy skin health. Its flagship products include a mouldable seal that fits securely around the stoma, preventing corrosive output from contacting the skin, and FLOWASSIST, which directs stoma output away from the skin to minimize irritation and swelling. By addressing these significant challenges faced by ostomy patients, Ostoform aims to improve comfort and overall quality of life, positioning itself as a potential leader in the global ostomy care market.

Intelligent Implants

Seed Round in 2021
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Kyomei

Seed Round in 2021
Kyomei is a company based in Oxford, England, focused on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei employs innovative techniques in plant cell biology to scale the production of myoglobin, which enhances the flavor profile of meat alternatives by providing umami. This approach not only aims to improve the taste of plant-based products but also seeks to reduce reliance on carbon-intensive animal agriculture, promoting a more sustainable food system for consumers.

EMYS

Convertible Note in 2021
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.

Pear Bio

Seed Round in 2021
Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Kutanios

Convertible Note in 2021
Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Kutanios

Seed Round in 2021
Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

IPOR

Seed Round in 2021
IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

VoltStorage

Series B in 2021
VoltStorage GmbH is a German company specializing in the development and production of solar energy storage systems. Based in Olching, Germany, it utilizes eco-friendly vanadium redox flow technology to create power storage devices that allow homeowners to store surplus solar energy generated during the day for use at night. This innovative approach aims to provide renewable energy availability around the clock, contributing to a cleaner and fairer world for future generations. VoltStorage also offers installation and technical support services for its products, which are sold online. The company's commitment to sustainability underscores its mission to enhance the accessibility of renewable energy.

Multus

Seed Round in 2021
Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Japet Medical

Seed Round in 2021
Japet Medical is a French biomedical company specializing in the development of robotic medical devices. Their focus lies in creating efficient and user-friendly solutions designed to enhance treatment quality and improve patients' lives.

QV Bioelectronics

Seed Round in 2021
QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Intelligent Implants

Convertible Note in 2021
Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

SAVA

Convertible Note in 2021
SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Maven Pet

Pre Seed Round in 2021
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Multus

Convertible Note in 2021
Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Synthace

Convertible Note in 2021
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Hexafly

Convertible Note in 2021
Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

DeepSpin

Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

viACT

Seed Round in 2021
viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Nordetect

Seed Round in 2021
Nordetect is a Copenhagen-based analytical hardware company established in 2016, specializing in Lab-on-a-chip devices for environmental and agricultural analysis. The company aims to enhance the farming industry by providing medical-grade technology that facilitates reliable nutrient analysis. Nordetect's innovative technology enables farm managers, agricultural service providers, and indoor growers to assess the nitrogen, phosphorus, and potassium content in soil. By delivering clear and actionable data on soil nutrition, the company empowers farmers to make informed decisions about fertilizer use and agricultural practices, ultimately optimizing crop performance and ensuring richer harvests.

Scantrust

Series B in 2021
ScanTrust SA is a company specializing in a cloud-based IoT platform that enhances supply chain visibility and product authentication. Founded in 2014 and headquartered in Lausanne, Switzerland, with operations in Shanghai, Singapore, and Bangkok, ScanTrust employs secure unique identifiers to connect products and packaging to the Internet. Its offerings include a printer portal for packaging and label partners to integrate secure codes into existing processes, an online portal for real-time business intelligence and supply chain insights, and secure QR codes that can be verified by smartphones. This technology enables brand owners to protect their products from counterfeiting while providing detailed supply chain control and opportunities for consumer engagement.

SunGreenH2

Seed Round in 2021
Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

Nordetect

Convertible Note in 2021
Nordetect is a Copenhagen-based analytical hardware company established in 2016, specializing in Lab-on-a-chip devices for environmental and agricultural analysis. The company aims to enhance the farming industry by providing medical-grade technology that facilitates reliable nutrient analysis. Nordetect's innovative technology enables farm managers, agricultural service providers, and indoor growers to assess the nitrogen, phosphorus, and potassium content in soil. By delivering clear and actionable data on soil nutrition, the company empowers farmers to make informed decisions about fertilizer use and agricultural practices, ultimately optimizing crop performance and ensuring richer harvests.

EMYS

Seed Round in 2021
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.

viACT

Seed Round in 2020
viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

Pear Bio

Seed Round in 2020
Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Flow Neuroscience

Convertible Note in 2020
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

TIER Mobility

Series C in 2020
TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.

Magellan Life Sciences

Seed Round in 2020
Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Moirai Biodesign

Convertible Note in 2020
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Aō Air

Convertible Note in 2020
Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.